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ABSTRACT 
 
This research formulate erythropoietin-alginate microspheres and to evaluate characteristics of 
erythropoietin-alginate microspheres at different amount of drug using aerosolization. Amount of 
erythropoietinare 10,000 IU (F1); 20,000 IU (F2); 60,000 IU (F3). The mixture of erythropoietin-
alginate was sprayed into CaCl2and was stirred at 1000 rpm for 30 minutes. Formulas resulted 
spherical shape of microspheres. The size of microspheres was 2.77 µm for F1; 3.89µm for F2; and 
4.42µm for F3. The results of swelling index showed that swelling index of microspheres increased by 
increasing the concentration of erythropoietin. The results were in accordance with the size of the 
microspheres that increased with increasing concentration of drug. The yields of microspheres 
obtained were respectively 91.92%; 87.53%; 86.50% for F1, F2 and F3. It can be concluded that the 
particle size of microspheres, swelling index increased by increasing concentration of erythropoietin. 
In contrast, yield of microspheres decreased by increasing drug concentration. In conclusion, formulas 
of microspheres were potential in terms of characteristics and may recommend for further in vivo 
study. 
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INTRODUCTION 
Erythropoietin is a 30.4 kDa glycoprotein hormone which is the main regulator of red blood cell 
production (Prenggono, 2015). Erythropoietin has a protective role against tissue ischaemia (Pachos, 
2008). Erythropoietin, which is a protein, has several weaknesses, such as unstable in biological fluids 
because of easily digested by enzymes, cannot be fully absorbed from the digestive tract due to a high 
molecular weight resulting to low bioavailability, and has short half-life (Wang et al., 2013). 
Erythropoietin is stable at pH 4-<9 and has the highest activity at pH 7-8 (Chang et al., 2013). 
Erythropoietin is also stable at -20°C or -70°C (Chang et al., 2013). At pH 9 and 40 °C, erythropoietin 
will undergo dimerization to form large molecules that can induce the body's immune response, which 
can harm patients (Chang et al., 2013). Some alternative is by formulatemicrospheressystem to release 
the drug in a sustained release manner (Chaudhary et al., 2010).  
Microspheres are a drug delivery system in which the drug is diluted or dispersed 
homogeneously in the polymer matrix (Kumar et al., 2011). The advantage of a microsphere delivery 
system is that the drug's release properties in the body occur gradually, making it suitable for carrying 
the necessary drugs into the body with a fixed amount. In addition, the microspheres can also protect 
peptide/protein drugs from hydrolytic enzyme attacks (Takada, 2008). 
The manufacture of erythropoietin microspheres by ionic gelation method and aerosolization 
technique requires polymers and crosslinking solutions. One of the most commonly used natural 
polymers is alginate.  
Alginate is a polysaccharide which is a salt of alginic acid, comprising a monomer (1-4)-β-D-
manuronic acid (unit M) and α-L-guluronic acid (unit G) that varies in quantity and distribution along 
its polymer chain (Pal et al., 2013). Na alginate is widely applied for biomedical purposes as a drug 
delivery system due to its biocompatibility, biodegradablity, low toxicity, relatively low cost, and 
lighter gelation by the addition of divalent cations such as Ca
2+
 (Hariyadi et al., 2014).  
The frequently used crosslinking cations are divalent and trivalent cations (Ahirrao et al, 2014). 
The addition of monovalent metal ions to the alginate will form a soluble salt (Lee and Money, 2012). 
Pb, Cu, Cd cations are rarely used because they have some toxicity (Zhai, 2012). The use of Ba and Sr 
cations should be in low concentration as they are slightly toxic (Zhai, 2012). Ca
2+
cations are often 
used because of their low toxicity and lack of high affinity for alginates (Zhai, 2012). 
The ionic gelation method is based on the ability of the polyelectrolyte to be crosslinked in the 
presence of crosslinking ions forming a hydrogel. This method is prepared by dripping the drug-
polymer solution into a cation polivalent solution. The cation diffuses into the droplets of a polymer 
solution, forming a three-dimensional crosslinked formation (Patil et al., 2012). The ionic gelation 
method is suitable for the active ingredients of proteins because of the simple and light process, which 
is greatly helpful for maintaining the bioactivity of the proteins (Koppolu et al., 2014). The advantage 
of the ionic gelation method is that all polyelectrolytes are diluted in the water so that the protein can 
be encapsulated without the use of organic solvents and the ionic gelation method does not use high 
temperatures so that protein integrity is maintained. In addition, this method is considered simple, fast, 
cost-effective, and has a small particle size diameter (Hariyadi et al., 2014). 
Microspheres that have been formed will undergo the drying process. The drying process of 
microspheres in this research was the freeze drying technique, because it is able to maintain protein 
integrity during the drying process (Abdelwahed et al., 2006). The freeze drying process requires 
pressure during the freezing and drying processes, requiring a lyoprotectant (Abdelwahed et al., 2006). 
A lyoprotectant can stabilize the microsphere through the mechanism of hydrogen bond formation 
with polar groups on the surface of the microsphere at the end of the drying process in order to 
maintain the microsphere structure and replace the water's position on the microsphere surface 
(Abdelwahed et al., 2006). One of the usable lyoprotectants is maltodextrin, because it protects protein 
stability during the freezing and drying (Hariyadi et al., 2014)  
Factors that may affect the characteristics of the resulting microsphere are the number of 
polymers, the number of crosslinkers, the amount of drug ingredients used, and the crosslinking time 
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(Jin et al., 2009). The higher the concentration of the drug, the higher the microspheres size that is 
obtained (Wang et al., 2013). In a study conducted by Balasubramaniam et al. (2007) on the effect of 
drug concentration on microsphere size using the emulsification technique, it was found that the 
greater the concentration of drug used, the greater the microsphere size that is obtained. This was 
because the higher the concentration of the drug, the greater the droplet size produced, resulting in the 
larger size of the formed microsphere (Balasubramaniam et al., 2007). The microspheres size range 
generated from the study was 47-50 μm (Balasubramaniam et al., 2007). In addition, increasing the 
concentrations of medicinal ingredients may also increase the efficiency of encapsulation 
(Balasubramaniam et al., 2007). The differences of the research conducted by Balasubramaniam et al. 
(2007) with this research is on aerosolization technique used in method of produced microspheres, 
therefore it is expected that the microsphere particle size formed is <5 μm. The determination of target 
size of microspheres of <5 μm is adjusted to the particle size requirement for suspensions (Patel, 
2010). 
 This study was conducted to determine the effect of erythropoietin amount(10,000, 20,000, 
60,000 IU) on erythropoietin-alginate microspheres characteristics using ionotropic gelation method 
and aerosolization technique. 
 
MATERIALS  AND METHODS 
Materials  
 Pharmaceutical grade Erythropoietin (Daewoong Inc.),  Sodium alginate (Sigma-Aldrich Inc.), 
CaCl2.2H2O (Solvay Chemicals International), demineralized water, pro-analysis Na2HPO4  (Merck), 
KH2PO4 (Merck), NaCl  (Merck), NaOH (Merck), and pharmaceutical grade Maltodextrin (PT 
Bratachem). 
 
Research Method 
Microspheres formula  
Sodium alginate (2 gram) were dissolved into 100 mL of demineralized water. Erythropoietin 
was dispersed into 100 mL of alginate solution based on drug concentration. After that, CaCl2 
solution2 1M was made in 200 ml aqua demineralized by stirring homogeneously. The formed 
erythropoietin-alginate solution was then sprayed into CaCl2 solution using aerosol spray with a 35 
μmhole size and a constant pressure of 40 psi while being continuously stirred using a magnetic stirrer 
at 1000 rpm for 30 minutes. The microspheres suspension that had been formed was centrifuged at 
4000 rpm for 10 minutes, then washed with demineralized water 3 times to separate the microspheres 
from the CaCl2 solution. The washed microspheres were collected and dried using the freeze drying 
technique at -26
ᵒ
C for 38 hours. 
 
Table I. Erythropoietin-alginate microspheres formulas 
 
Materials Function F1 F2 F3 
Erythropoietin Active agent 10.000 IU 20.000 IU 60.000 IU 
Na Alginate Polymer 2% (in 100ml) 2% (in 100ml) 2% (in 100ml) 
CaCl2 Crosslinker 1 M(in 200 ml) 1 M (in 200 ml) 1 M (in 200ml) 
Maltodextrin Lyoprotectant 
5%  
(from wet 
microspheres 
weight)  
5%  
(from wet 
microspheres 
weight) 
5%  
(from wet 
microspheres 
weight) 
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Evaluation of erythropoetin-alginate microspheres 
 Particle size distribution  
The evaluation of erythropoietin-alginate microsphere size distribution was performed using 
400x optical microscope magnification. The diameter of erythropoietin-alginate microspheres was 
observed with a 400x magnification of 300 particles. Then, the mean diameter was determined and the 
microsphere size distribution curve was made. The average diameter was calculated using the formula: 
 
dvs =  
 
 Microspheres shape and surface morphology 
The morphological evaluation of erythropoietin-alginate microspheres and surface forms was 
performed using a Scanning Electron Microscope (SEM). This evaluation was performed by placing a 
sample on the handle of the preparation with an adhesive material containing metal grains, such as the 
metal Pt. The gold in the Chamber was evaporated so that the gold steam coated the entire surface of 
the microparticles. The surface of the gold-coated microparticles was observed using SEM to observe 
the morphology of the shape and surface of the microspheres. 
 
 Moisture content determination 
The moisture content determination on erythropoietin alginate microspheres can be determined 
using the moisture balance. This evaluation can be performed by weighing 0.5 grams of microspheres 
and inserting them into the moisture balance. The tool would work for 10 minutes. The moisture 
content (MC) was calculated by the equation: MC =  
 
Determination of Swelling Index (SI) 
The determination of swelling index was performed by weighing 50 mg microspheres and then 
adding 5 ml PBS pH 7.4 in a vial. The swelling index determination was performed at 24 and 30 
hours. After the observation time had been reached, the wet microspheres were filtered using filter 
paper. After no PBS was dripped from the filter paper, the wet microspheres were transferred to a dry 
filter pad and then the microspheres were flipped continuously to remove the adsorbed water on the 
microsphere surface until the filter paper became not too wet. Afterwards, the wet microspheres were 
stirred at 37ᵒC for 2 hours or until the microspheres weight became constant. The microspheres was 
weighed as the swelling weight. The swelling index (SI) value was calculated using the formula:  
 
SI =  
  
The swelling index observation was also performed based on the microsphere ssize. A little 
amount of microsphere were taken to be observed for microspheres size during swelling using an 
optical microscope. The swelling index (SI) value was calculated using the formula:  
 
 
 
Yield determination 
The yield value was determined by the ratio of the total weight of the dry microspheres obtained 
to the amount of weight of erythropoietin, sodium alginate, and maltodextrin. The yield value can be 
calculated by the formula: 
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The data from each examination were compared with each of the formulas. The data analysis was 
performed using SPSS 23 statistical program using the One Way ANOVA method. 
 
RESULTS AND DISCUSSION 
The mean diameter for blank microspheres was 2.31 μm and the mean diameters of F1 
microspheres, F2, F3 using 400 times magnification were 2.77 ± 0.08 μm; 3.89 ± 0.12 μm; and 4.42 ± 
0.06μmrespectively (Figure 1). These results indicated that blank microspheres were smaller than the 
three formulas microspheres with erythropoietin. The observation also showed an increase in the size 
of the microsphere as the levels concentration of erythropoietin from F1 to F3 increased with the 
values of 10,000, 20,000, and 60,000 IU. The average microspheres diameter result met the 
specification of <5μm, where the size is considered good for a parenteral suspension (Patel, 2010). 
 
 
 
 
 
 
 
 
 
Figure 1.Histogram of diameters of microspheres sizes of blank microspheres and microspheres 
of F1, F2 and F3  
 
The microspheres size increased by addition of erythropoietin levels was due to two factors. 
First, the higher the amount of erythropoietin, the more erythropoietin can filled the remaining empty 
egg-box structures. Second, there was a repulsive force between erythropoietin and alginate. Alginate 
as a bioelectrolyte can caused repulsive force with erythropoietin. The repulsive force occurred 
between the COO
-
group of alginate with the COO 
-
 group of erythropoietin. The larger the 
erythropoietin, the greater the repulsive force that occurs with alginate. The existence of such repulsive 
forces may increase the viscosity, resulting in increased microsphere size (Chaudhari et al., 2015).  
In the analysis of the effect of erythropoietin levels on microspheres, sig values of 0.000<0.05 
for F1:F2; 0.000<0.05 for F1:F3; and 0.001 <0.05 for F2:F3 were obtained. The three comparisons of 
the formula showed sig values of <0.05, so we can say there is a significant difference in microsphere 
size between F1, F2, and F3. 
The morphological observations of the shape and surface of the microspheres using the 
Scanning Electron Microscope (SEM) of the F1, F2, F3resulted in spherical and smooth shapes 
(Figure 2). These results can be obtained due to the addition of maltodextrin as a lyoprotectant which 
made the form of the microsphere to be spherical with a smooth and flat surface. The maltodextrin 
would filled the cavity on the surface of the microsphere and form the hydrogen bond with the polar 
group on the microsphere surface during the freeze drying process (Abdelwahed et al., 2006).  
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Figure 2. The shape and surface morphology of the erythropoietin microspheres (A) F1, (B) F2, 
(C) F3 observed using the ScanningElectron Microscopy at 5000x magnification 
 
The result of MC determination showed that the average of water content in the three formulas 
were 5.85 ± 0.10%; 5.08 ± 0.13%; and 8.08 ± 0.21% as seen in Table I. The MC of three formulas 
corresponded to specifications of MC of <10%. The high moisture content can decreased the stability 
of the active ingredients in the microspheres due to the formation of particle agglomeration (Shan et 
al., 2016).  
Table II. Moisture content of microspheres formula 
 
Microspheres Formula MC (%) ± SD CV (%) 
F1 5.85 ± 0.10 1.71 
F2 5.08 ± 0.13 2.56 
F3 8.08 ± 0.21 2.60 
 
 From the determination of swelling index, the average swelling index at 24 hours based on the 
weights of microspheres in formula F1, F2 and F3 were 1.300 ± 0.071; 1.463 ± 0.046; 1.749 ± 0.044, 
while during the observation at 30 hours, the average swelling index based on the weight of the 
microsphere in the formula F1, F2, and F3 were 1.867 ± 0.056; 2.272 ± 0.154; 2.475 ± 0.189. The 
average swelling indices at 24 hours based on microspheres sizes in the formula F1, F2, and F3 were 
1.13 ± 0.10; 1.37 ± 0.05; 1.67 ± 0.04, respectively. Meanwhile, during the observation at 30 hours, the 
(C) 
(B) (A) 
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average swelling indices based on the microspheres size in formulas F1, F2, and F3 were 1.85 ± 0.04; 
2.07 ± 0.12; 2.28 ± 0.15. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The swelling index histogram based on weight of microspheres F1, F2, F3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The swelling index histogram based on the size of microspheres of F1, F2, F3 
 
The average swelling indices based on microsphere weight at 24 hours and 30 hours yielded 
gave greater result than swelling indices based on microspheres sizes. However, if it was tested 
statistically using the independent t-test, the difference of swelling indices between microsphere 
weight and microsphere size was not significant due to the 2-tailed sig value > 0.05. The increase of 
swelling index values at 24 to 30 hours based on the weight and size of microspheres can be said to 
differ significantly because the independent t-test results showed that the 2-tailed sig value < 0.05. 
 When we looked at the average swelling index results, both based on microsphere weight and 
microsphere size, it seems that both yielded the same resulted that the swelling index value increased 
with the increased of the ingredients added in the formula. This corresponded to the average yield of 
microspheres in which microsphere sizes increased with the ingredients added in the formula. The 
swelling index results based on microsphere weight and microspheres size were also in accordance 
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with the theory, where the higher the observation time, the higher the swelling index value was 
obtained (Navneet et al., 2011).   
 The swelling index evaluation was used to ensure the polymer can expand, then it can released 
drug. Alginate, in releasing drug substances, had diffusion, swelling, and erosion mechanisms 
(Fernanda et al., 2014). The results of the evaluation have been found to be in accordance with the 
theory in which alginate can expand, as evidenced by the addition of weight and size of microspheres 
after being put aside for 24 and 30 hours.  
 From the result of yield determination, the average yields obtained in formula F1, F2, and F3 
were 91.92 ± 3.33%; 87.53 ± 6.01%; 86.50 ± 4.59%. From these results, it is known that the value of 
the yield fallen along with the increase of the ingredient content of the drug added in the formula. This 
was because microspheres have entrapment capacities in entrapping drug ingredients (Rastogi et al., 
2007). The increasing yield values indicated that erythropoietin with a level of >10,000 IU is not 
entirely entrapped in the microspheres and was dissolved when washed with water since erythropoietin 
was also soluble in water. The results of statistical analysis showed that the effect of erythropoietin 
content on yield was mas determined by sig values of 0.534>0.05 for F1: F2; 0.403> 0.05 for F2: F3; 
and 0.963> 0.05 for F2: F3. The three comparisons of the formula showed sig values of < 0.05, so we 
can say there is a significant difference in microspheres size between F1, F2, and F3.  
 
 
 
 
 
 
 
 
 
 
Figure 5. Histogram of % yield of microspheres of F1, F2, F3  
 
 
CONCLUSION 
The formulation of erythropoietin-alginate microspheres by the ionic gelation method and 
aerosolization technique with different erythropoietin amount (10,000, 20,000, 60,000 IU) resulted in 
microspheres which were spherical and smooth. Increasing levels of erythropoietin increased the size 
of the microspheres and swelling index significantly, but did not have a significant effect on yield. 
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